financetom
Business
financetom
/
Business
/
--Hormel Foods Keeps Quarterly Dividend at $0.29 per Share; Payable May 15 to Shareholders as of April 14
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
--Hormel Foods Keeps Quarterly Dividend at $0.29 per Share; Payable May 15 to Shareholders as of April 14
Mar 25, 2025 7:35 AM

10:06 AM EDT, 03/25/2025 (MT Newswires) --

Price: 29.03, Change: -0.24, Percent Change: -0.80

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Constellation Energy's Q1 Adjusted Operating Earnings Rise, Operating Revenue Falls
Constellation Energy's Q1 Adjusted Operating Earnings Rise, Operating Revenue Falls
May 9, 2024
07:15 AM EDT, 05/09/2024 (MT Newswires) -- Constellation Energy ( CEG ) reported Q1 adjusted operating earnings Thursday of $1.82 per diluted share, up from $0.78 a year earlier. Analysts polled by Capital IQ expected $1.29. Operating revenue for the quarter ended March 31 was $6.16 billion, compared with $7.57 billion a year earlier. Three analysts surveyed by Capital IQ...
Privia Health Group Adjusted Earnings, Revenue Rise in Q1; Offers Full Year 2024 Revenue Guidance
Privia Health Group Adjusted Earnings, Revenue Rise in Q1; Offers Full Year 2024 Revenue Guidance
May 9, 2024
07:00 AM EDT, 05/09/2024 (MT Newswires) -- Privia Health Group ( PRVA ) reported Q1 earnings Thursday of $0.18 per share, up from $0.16 a year earlier. Analysts polled by Capital IQ expected $0.15. Revenue for the quarter ended March 31 was $415.2 million, up from $386.3 million a year earlier. Analysts surveyed by Capital IQ expected $394.8 million. The...
Metaphore Biotechnologies to partner with Novo Nordisk on obesity therapies
Metaphore Biotechnologies to partner with Novo Nordisk on obesity therapies
May 9, 2024
May 9 (Reuters) - Metaphore Biotechnologies said on Thursday it would collaborate with Novo Nordisk to develop up to two therapies for obesity management. (Reporting by Puyaan Singh in Benagluru; Editing by Anil D'Silva) ...
Merck's endometrial cancer therapy fails trial
Merck's endometrial cancer therapy fails trial
May 9, 2024
May 9 (Reuters) - Merck ( MRK ) said on Thursday its therapy did not meet the main goal of disease-free survival in certain patients with endometrial cancer during a late-stage trial. The drugmaker's Keytruda therapy in combination with chemotherapy was being evaluated in patients with high-risk endometrial cancer after surgery. The study's other main goal of overall survival was...
Copyright 2023-2026 - www.financetom.com All Rights Reserved